Calixto JB, Scheidt C, Otuki M, Santos AR. Biological activity of plant extracts: novel analgesic drugs. Expert OpinEmerg Drugs. 2001 Oct;6(2):261-79.doi: 10.1517/14728214.6.2.261. PMID: 15989526.
Desborough, M.J.R. and Keeling, D.M., The aspirin story – from willow to wonder drug. Br J Haematol, 2017, 177: 674-683. https://doi.org/10.1111/bjh.14520
Vlachojannis J, Magora F, Chrubasik S. Willow species and aspirin: different mechanism of actions. Phytother Res. 2011 Jul;25(7):1102-4. doi: 10.1002/ptr.3386. PMID: 21226125.
Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extract: A randomized double blind study. Am J Med. 2000;9:9–14.
Chrubasik S, Künzel O, Model A, Conradt C, Black A. Treatment of low back pain with a herbal or synthetic anti-rheumatic: A randomized controlled study. Willow bark extract for low back pain. Rheumatology. 2001;40:1388–93.
Fiebich BL, Chrubasik S. Effects of an ethanolic Salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine. 2004;11:135–8.
Gagnier JJ, vanTulder M, Berman B, Bombardier C. Herbal medicine for low back pain. Cochrane Database Syst Rev. 2006;19:CD004504.
Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998;339:847.
Schmid B, Kótter I, Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J ClinPharmacol. 2001;57:387–91.
Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. 1996 Dec;48(4):567-92. PMID: 8981566.
Duarte DF. Uma breve história do ópio e dos opióides [Opium and opioids: a brief history.]. Rev Bras Anestesiol. 2005 Feb;55(1):135-46. Portuguese. PMID: 19471817.
McQuay H. Opioids in pain management. Lancet. 1999 Jun 26;353(9171):2229-32. doi: 10.1016/S0140-6736(99)03528-X. PMID: 10393001.
LessaMA ,Cavalcanti IL , Figueiredo NV. Cannabinoid derivatives and the pharmacological management of pain. Rev Dor. São Paulo, 2016 jan-mar;17(1):47-51
Dmitrieva N, Nagabukuro H, Resuehr D, Zhang G, McAllister SL, McGinty KA, Mackie K, Berkley KJ. Endocannabinoid involvement in endometriosis. Pain. 2010 Dec;151(3):703-710. doi: 10.1016/j.pain.2010.08.037. Epub 2010 Sep 15. PMID: 20833475; PMCID: PMC2972363.
Lynch, M.E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. British Journal of Clinical Pharmacology.2011; 72: 735-744. https://doi.org/10.1111/j.1365-2125.2011.03970
Romero-Sandoval, E.A., Kolano, A.L. & Alvarado-Vázquez, P.A. Cannabis and Cannabinoids for Chronic Pain. CurrRheumatol Rep 19, 67 (2017). https://doi.org/10.1007/s11926-017-0693-1
Boyaji, S., Merkow, J., Elman, R.N. et al. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence. Curr Pain Headache Rep 24, 4 (2020). https://doi.org/10.1007/s11916-020-0835-4
Noori A, Miroshnychenko A, Shergill Y, et alOpioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studiesBMJ Open 2021;11:e047717. doi: 10.1136/bmjopen-2020-047717
Fitzcharles MA, Baerwald C, Ablin J, Häuser W. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials. Schmerz (Berlin, Germany). 2016 Feb;30(1):47-61. DOI: 10.1007/s00482-015-0084-3. PMID: 26767993.
Thanh B, Tung &Đồng, Nhâm& Nguyen, Hai & Dang, Kim. Curcuma longa, the Polyphenolic Curcumin Compound and Pharmacological Effects on Liver. 2019.doi: 10.1016/B978-0-12-814466-4.00010-0.
Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016 Aug;19(8):717-29. doi: 10.1089/jmf.2016.3705. PMID: 27533649; PMCID: PMC5003001.
Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012 Nov;26(11):1719-25. doi: 10.1002/ptr.4639. Epub 2012 Mar 9. PMID: 22407780.
Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res. 2014 Nov;28(11):1625-31. doi: 10.1002/ptr.5174. Epub 2014 May 22. PMID: 24853120.
Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, Saengsuwan J, Tantayakom K, Laongpech S. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. ClinInterv Aging. 2014 Mar 20;9:451-8. doi: 10.2147/CIA.S58535. PMID: 24672232; PMCID: PMC3964021.
Rahimnia AR, Panahi Y, Alishiri G, Sharafi M, Sahebkar A. Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial. Drug Res (Stuttg). 2015 Oct;65(10):521-5. doi: 10.1055/s-0034-1384536. Epub 2014 Jul 22. PMID: 25050518.
Devaraj SD, Neelakantan P. Curcumin- Pharmacological actions and its role in dentistry. Indian J Dent Res. 2009;20:107-9
Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. Neurosci Bull. 2012 Jun;28(3):253-8. doi: 10.1007/s12264-012-1238-2. PMID: 22622825; PMCID: PMC5560326.
Mythri RB, Bharath MM. Curcumin: a potential neuroprotective agent in Parkinson's disease. Curr Pharm Des. 2012;18(1):91-9. doi: 10.2174/138161212798918995. PMID: 22211691.
Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL. Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review. BMC Complement Altern Med. 2017 Aug 17;17(1):412. doi: 10.1186/s12906-017-1922-x. PMID: 28818104; PMCID: PMC5561616.
Nebrisi EE, Javed H, Ojha SK, Oz M, Shehab S. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors. Int J Mol Sci. 2020 Oct 3;21(19):7329. doi: 10.3390/ijms21197329. PMID: 33023066; PMCID: PMC7583812.
Nebrisi EE. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature. Int J Mol Sci. 2021 Oct 18;22(20):11248. doi: 10.3390/ijms222011248. PMID: 34681908; PMCID: PMC8537234.
Ammon HP. Boswellic Acids and Their Role in Chronic Inflammatory Diseases. AdvExp Med Biol. 2016;928:291-327. doi: 10.1007/978-3-319-41334-1_13. PMID: 27671822.
Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J PharmacolExpTher. 1992 Jun;261(3):1143-6. PMID: 1602379.
Maroon JC, Bost JW, Maroon A. Natural anti-inflammatory agents for pain relief. SurgNeurol Int. 2010 Dec 13;1:80. doi: 10.4103/2152-7806.73804. PMID: 21206541; PMCID: PMC3011108.
Shahid Akbar. Handbook of 200 Medicinal Plants: A Comprehensive Review of Their Traditional Medical Uses and Scientific Justifications. 1st ed. 2020. Springer. ISBN -13 978-3030168063
Poeckel D, Werz O. Boswellic acids: biological actions and molecular targets. Curr Med Chem. 2006;13(28):3359-69. doi: 10.2174/092986706779010333. PMID: 17168710.
Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswelliaserrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. ClinPharmacokinet. 2011 Jun;50(6):349-69. doi: 10.2165/11586800-000000000-00000. PMID: 21553931.
Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci. 2001;24:487-517. doi: 10.1146/annurev.neuro.24.1.487. PMID: 11283319.
Chung JM, Lee KH, Hori Y, Willis WD. Effects of capsaicin applied to a peripheral nerve on the responses of primate spinothalamic tract cells. Brain Res. 1985 Mar 11;329(1-2):27-38. doi: 10.1016/0006-8993(85)90509-8. PMID: 3978447.
Chung MK, Campbell JN. Use of Capsaicin to Treat Pain: Mechanistic and Therapeutic Considerations. Pharmaceuticals (Basel). 2016 Nov 1;9(4):66. doi: 10.3390/ph9040066. PMID: 27809268; PMCID: PMC5198041.
Girhepunje NS, Dumore NG, Taksande SU, ChaudhariDV,Shende SN. Gingerol: A review. IJMRPS. 2017; 4 (3)
Pagano E, Souto EB, Durazzo A, Sharifi-Rad J, Lucarini M, Souto SB, Salehi B, Zam W, Montanaro V, Lucariello G, Izzo AA, Santini A, Romano B. Ginger (Zingiberofficinale Roscoe) as a nutraceutical: Focus on the metabolic, analgesic, and antiinflammatory effects. Phytother Res. 2020 Dec 5. doi: 10.1002/ptr.6964. Epub ahead of print. PMID: 33278054.
Young HY, Luo YL, Cheng HY, Hsieh WC, Liao JC, Peng WH. Analgesic and anti-inflammatory activities of [6]-gingerol. J Ethnopharmacol. 2005 Jan 4;96(1-2):207-10. doi: 10.1016/j.jep.2004.09.009. PMID: 15588672.
Gauthier ML, Beaudry F, Vachon P. Intrathecal [6]-gingerol administration alleviates peripherally induced neuropathic pain in male Sprague-Dawley rats. Phytother Res. 2013 Aug;27(8):1251-4. doi: 10.1002/ptr.4837. Epub 2012 Sep 12. PMID: 22972597.
Hitomi S, Ono K, Terawaki K, Matsumoto C, Mizuno K, Yamaguchi K, Imai R, Omiya Y, Hattori T, Kase Y, Inenaga K. [6]-gingerol and [6]-shogaol, active ingredients of the traditional Japanese medicine hangeshashinto, relief oral ulcerative mucositis-induced pain via action on Na+ channels. Pharmacol Res. 2017 Mar;117:288-302. doi: 10.1016/j.phrs.2016.12.026. Epub 2016 Dec 30. PMID: 28043879.
Mata-Bermudez A, Izquierdo T, de Los Monteros-Zuñiga E, Coen A, Godínez-Chaparro B. Antiallodynic effect induced by [6]-gingerol in neuropathic rats is mediated by activation of the serotoninergic system and the nitric oxide-cyclic guanosine monophosphate-adenosine triphosphate-sensitive K+ channel pathway. Phytother Res. 2018 Dec;32(12):2520-2530. doi: 10.1002/ptr.6191. Epub 2018 Sep 24. PMID: 30251306.
Hitomi, Suzuro& Ono, Kentaro&Terawaki, Kiyoshi & Matsumoto, Chinami & Mizuno, Keita & Yamaguchi, Kiichiro & Imai, Ryota& Omiya, Yuji & Hattori, Tomohisa&Kase, Yoshio &Inenaga, Kiyotoshi. (2016). [6]-gingerol and [6]-shogaol, active ingredients of the traditional Japanese medicine hangeshashinto, relief oral ulcerative mucositis-induced pain via action on Na+ channels. Pharmacological Research. 117. 10.1016/j.phrs.2016.12.026.
Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation. 2007 Apr;30(1-2):1-6. doi: 10.1007/s10753-006-9012-0. PMID: 17115116.
Tao L, Ding Q, Gao C, Sun X. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. IntImmunopharmacol. 2016 May;34:165-172. doi: 10.1016/j.intimp.2016.02.033. Epub 2016 Mar 5. PMID: 26953646.
Takeda M, Takehana S, Sekiguchi K, Kubota Y, Shimazu Y. Modulatory Mechanism of Nociceptive Neuronal Activity by Dietary Constituent Resveratrol. International Journal of Molecular Sciences. 2016; 17(10):1702.
Zhu H, Ding J, Wu J, Liu T, Liang J, Tang Q, Jiao M. Resveratrol attenuates bone cancer pain through regulating the expression levels of ASIC3 and activating cell autophagy. ActaBiochimBiophys Sin (Shanghai). 2017 Nov 1;49(11):1008-1014. doi: 10.1093/abbs/gmx103. PMID: 29036449.
Marouf BH, Hussain SA, Ali ZS, Ahmmad RS. Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated with Meloxicam: A Randomized Placebo-Controlled Study. J Med Food. 2018 Aug 30. doi: 10.1089/jmf.2017.4176. Epub ahead of print. PMID: 30160612.
Hussain SA, Marouf BH, Ali ZS, Ahmmad RS. Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study. ClinInterv Aging. 2018 Sep 5;13:1621-1630. doi: 10.2147/CIA.S172758. PMID: 30233159; PMCID: PMC6130538.
Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look at this ancient compound. J Am AcadDermatol. 2007 Nov;57(5):873-8. doi: 10.1016/j.jaad.2007.04.008. Epub 2007 May 10. PMID: 17498839.
Barkin RL. The pharmacology of topical analgesics. Postgrad Med. 2013 Jul;125(4 Suppl 1):7-18. doi: 10.1080/00325481.2013.1110566911. PMID: 24547599.
Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A, Ghelardini C. Menthol: a natural analgesic compound. Neurosci Lett. 2002 Apr 12;322(3):145-8. doi: 10.1016/s0304-3940(01)02527-7. PMID: 11897159.
Zhang J, Enix D, Snyder B, Giggey K, Tepe R. Effects of Biofreeze and chiropractic adjustments on acute low back pain: a pilot study. J Chiropr Med. 2008 Jun;7(2):59-65. doi: 10.1016/j.jcme.2008.02.004. PMID: 19674721; PMCID: PMC2682942.
Derry S, Sven-Rice A, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007393. doi: 10.1002/14651858.CD007393.pub3. Update in: Cochrane Database Syst Rev. 2017 Jan 13;1:CD007393. PMID: 23450576.
Patel R, Gonçalves L, Leveridge M, Mack SR, Hendrick A, Brice NL, Dickenson AH. Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: a comparison with topical menthol. Pain. 2014 Oct;155(10):2097-107. doi: 10.1016/j.pain.2014.07.022. Epub 2014 Jul 30. PMID: 25083927; PMCID: PMC4220012.
Fallon MT, Storey DJ, Krishan A, Weir CJ, Mitchell R, Fleetwood-Walker SM, Scott AC, Colvin LA. Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist. Support Care Cancer. 2015 Sep;23(9):2769-77. doi: 10.1007/s00520-015-2642-8. Epub 2015 Feb 15. PMID: 25680765; PMCID: PMC4519585.
Fallon MT, Storey DJ, Krishan A, Weir CJ, Mitchell R, Fleetwood-Walker SM, Scott AC, Colvin LA. Cancer treatment-related neuropathic pain: proof of concept study with menthol—a TRPM8 agonist. Supportive Care in Cancer. 2015 Sep;23:2769-77.
Cortellini A, Verna L, Cannita K, Napoleoni L, Parisi A, Ficorella C, Porzio G. Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy. Indian J Palliat Care. 2017 Jul-Sep;23(3):350-352. doi: 10.4103/IJPC.IJPC_23_17. PMID: 28827946; PMCID: PMC5545968.
